Finance
Pacific Biosciences surges on $1.2 billion takeover offer from DNA sequencing company Illumina (ILMN, PACB)
- DNA sequencing company Illumina announced in a press release that it was acquiring Pacific Biosciences for approximately $1.2 billion. Illumina expects to close the transaction in mid-2019.
- Illumina offered $8 a share for Pacific Biosciences. Pacific Biosciences shares jumped 67% in late trading to $7.51
- Pacific Biosciences is a company that also specializes in gene sequencing. Pacific Biosciences CEO Michael Hunkapiller said in the press release that the two companies have complementary technology capabilities for analyzing genes, and when combined, will open “new frontiers of genomic utility.”
Continue Reading
-
Business6 days ago
AI chip startup DEEPX secures $80M Series C at a $529M valuation
-
Entertainment5 days ago
Jinkx Monsoon promises ‘the queerest season of ‘Doctor Who’ you’ve ever seen!’
-
Business5 days ago
StrictlyVC London welcomes Phoenix Court and WEX
-
Business7 days ago
Retell AI lets businesses build ‘voice agents’ to answer phone calls
-
Entertainment5 days ago
How to watch every ‘Law and Order’ online in 2024
-
Entertainment5 days ago
BookTok and teens: What parents need to know
-
Business4 days ago
Why Apple’s ‘Crush’ ad is so misguided
-
Entertainment6 days ago
'House of the Dragon' recap: Every death, ranked by gruesomeness